Skip to main content

Advertisement

Log in

Simvastatin reduces VCAM-1 expression in human umbilical vein endothelial cells exposed to lipopolysaccharide

  • Original Research Paper
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Objective

Reducing the expression of endothelial cell adhesion molecules (ECAMs) is known to decrease inflammation-induced vascular complications. In this paper we looked at whether statins can reduce inflammation-induced ECAM expression after lipopolysaccharide (LPS) treatment in endothelial cells.

Methods

Human umbilical vein endothelial cells (HUVECs) were pretreated with different concentrations of simvastatin, atorvastatin, and rosuvastatin and subsequently exposed to 5 μg/ml LPS. Semi-quantitative RT-PCR analysis was used to measure the mRNA expression of ECAMs, including VCAM-1, ICAM-1, and E-selectin.

Results

VCAM-1 mRNA appeared to be the only target that was affected by the statins, with its expression being partially and almost completely reduced by simvastatin at 50 and 125 μM concentrations, respectively, and only partially reduced by atorvastatin, but not reduced by rosuvastatin. VCAM-1 protein production was inhibited by simvastatin at concentrations from 5 to 125 μM. Leukocyte–endothelial cell adhesion assay revealed that simvastatin could inhibit the adhesion of labelled U937 cells to the HUVEC monolayer.

Conclusions

This study showed that simvastatin reduces VCAM-1 expression in HUVECs exposed to LPS and decreases leukocyte–endothelial cell adhesion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

ECAMs:

Endothelial cell adhesion molecules

VCAM-1:

Vascular cell adhesion molecule-1

ICAM-1:

Intercellular cell adhesion molecule-1

E-selectin:

Endothelial cell selectin

HUVECs:

Human umbilical vein endothelial cells

LPS:

Lipopolysaccharide

References

  1. Meng CQ. Atherosclerosis is an inflammatory disorder after all. Curr Top Med Chem. 2006;6:93–102.

    Article  PubMed  CAS  Google Scholar 

  2. Nakabe N, Kokura S, Shimozawa M, Katada K, Sakamoto N, Ishikawa T, et al. Hyperthermia attenuates TNF-alpha-induced up regulation of endothelial cell adhesion molecules in human arterial endothelial cells. Int J Hyperthermia. 2007;23:217–24.

    Article  PubMed  CAS  Google Scholar 

  3. Panes J, Perry M, Granger DN. Leukocyte–endothelial cell adhesion: avenues for therapeutic intervention. Br J Pharmacol. 1999;126:537–50.

    Article  PubMed  CAS  Google Scholar 

  4. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature. 1990;343:425–30.

    Article  PubMed  CAS  Google Scholar 

  5. Gotto AM Jr. Safety and statin therapy: reconsidering the risks and benefits. Arch Intern Med. 2003;163:657–9.

    Article  PubMed  Google Scholar 

  6. Gotto AM Jr. Statins, cardiovascular disease, and drug safety. Am J Cardiol. 2006;97:3C–5C.

    PubMed  Google Scholar 

  7. Greenwood J, Mason JC. Statins and the vascular endothelial inflammatory response. Trends Immunol. 2007;28:88–98.

    Article  PubMed  CAS  Google Scholar 

  8. Shitara Y, Sugiyama Y. Pharmacokinetic and pharmacodynamics alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug–drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacol Ther. 2006;112:71–105.

    Article  PubMed  CAS  Google Scholar 

  9. Matheny HE, Deem TL, Cook-Mills JM. Lymphocyte migration through monolayers of endothelial cell lines involves VCAM-1 signaling via endothelial cell NADPH oxidase. J Immunol. 2000;164:6550–9.

    PubMed  CAS  Google Scholar 

  10. Teupser D, Bruegel M, Stein O, Stein Y, Thiery J. HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells. Biochem Biophys Res Commun. 2001;289:838–44.

    Article  PubMed  CAS  Google Scholar 

  11. Rasmussen LM, Hansen PR, Nabipour MT, Olesen P, Kristiansen MT, Ledet T. Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells. Biochem J. 2001;360:363–70.

    Article  PubMed  CAS  Google Scholar 

  12. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N. Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats. Stroke. 2008;39:1276–85.

    Article  PubMed  CAS  Google Scholar 

  13. Zapolska-Doqnar D, Siennicka A, Kaczmarczyk M, Kołodziej B, Naruszewicz M. Simvastatin modulates TNFalpha-induced adhesion molecules expression in human endothelial cells. Life Sci. 2004;75:1287–302.

    Article  Google Scholar 

  14. Landsberger M, Wolff B, Jantzen F, Rosenstengel C, Vogelgesang D, Staudt A, et al. Cerivastatin reduces cytokine-induced surface expression of ICAM-1 via increased shedding in human endothelial cells. Atherosclerosis. 2007;190:43–52.

    Article  PubMed  CAS  Google Scholar 

  15. Bolaños JP, Almeida A, Stewart V, Peuchen S, Land JM, Clark JB, et al. Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J Neurochem. 1997;68:2227–40.

    Article  PubMed  Google Scholar 

  16. Yan W, Zhao K, Jiang Y, Huang Q, Wang J, Kan W, et al. Role of p38 MAPK in ICAM-1 expression of vascular endothelial cells induced by lipopolysaccharide. Shock. 2002;17:433–8.

    Article  PubMed  Google Scholar 

  17. Deisher TA, Haddix TL, Montgomery KF, Pohlman TH, Kaushansky K, Harlan JM. The role of protein kinase C in the induction of VCAM-1 expression on human umbilical vein endothelial cells. FEBS Lett. 1993;331:285–90.

    Article  PubMed  CAS  Google Scholar 

  18. Eccles KA, Sowden H, Porter KE, Parkin SM, Homer-Vanniasinkam S, Graham AM. Simvastatin alters human endothelial cell adhesion molecule expression and inhibits leukocyte adhesion under flow. Atherosclerosis. 2008;200:69–79.

    Article  PubMed  CAS  Google Scholar 

  19. Hinkelmann U, Grosser N, Erdmann K, Schröder H, Immenschuh S. Simvastatin-dependent up-regulation of heme oxygenase-1 via mRNA stabilization in human endothelial cells. Eur J Pharm Sci. 2010;41:118–24.

    Article  PubMed  CAS  Google Scholar 

  20. Baek D, Villén J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature. 2008;455:64–71.

    Article  PubMed  CAS  Google Scholar 

  21. Ziviani L, Da Ros L, Squassante L, Milleri S, Cugola M, Iavarone LE. The effects of lacidipine on the steady/state plasma concentrations of simvastatin in healthy subjects. Br J Clin Pharmacol. 2001;51:147–52.

    PubMed  CAS  Google Scholar 

  22. van der Spek E, Bloem AC, van de Donk NW, Bogers LH, van der Griend R, Kramer MH, de Weerdt O, Wittebol S, Lokhorst HM. Dose-finding study of high-dose simvastatin combined with standard chemotherapy in patients with relapsed or refractory myeloma or lymphoma. Haematologica. 2006;91:542–5.

    PubMed  Google Scholar 

Download references

Acknowledgments

The work was supported by the Chang Gung Memorial Hospital (CMRPG880511), Taiwan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ching-Hua Hsieh.

Additional information

Responsible Editor: Makoto Katori.

J.C.-S. Yang and F. Huang contributed equally to the work as the first author.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, J.CS., Huang, F., Wu, CJ. et al. Simvastatin reduces VCAM-1 expression in human umbilical vein endothelial cells exposed to lipopolysaccharide. Inflamm. Res. 61, 485–491 (2012). https://doi.org/10.1007/s00011-012-0435-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-012-0435-9

Keywords

Navigation